Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bernard Flourié Aurélien Amiot Benjamin Pariente Guillaume Bouguen Mathurin Fumery Anthony Buisson Xavier Roblin Anne Bourrier Hedia Brixi Pierre Michetti Vered Abitbol Matthieu Allez Yoram Bouhnik David Laharie Bernard Duclos Jérôme Filippi Laurent Peyrin-Biroulet |
| Publication date | September 30, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |